PCVX – vaxcyte, inc. (US:NASDAQ)
Stock Stats
News
Vaxcyte (NASDAQ:PCVX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Vaxcyte (NASDAQ:PCVX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
Vaxcyte's Chief Technical Ops Officer Sells Shares [Yahoo! Finance]
What Makes Vaxcyte (PCVX) So Attractive [Yahoo! Finance]
How Vaxcyte's Phase 3 Head-to-Head VAX-31 Trial Could Shape Vaxcyte (PCVX) Investors [Yahoo! Finance]
Form 4 Vaxcyte, Inc. For: Jan 14 Filed by: GUGGENHIME ANDREW
Form 4 Vaxcyte, Inc. For: Jan 14 Filed by: PICKERING GRANT
Form 4 Vaxcyte, Inc. For: Jan 15 Filed by: BRANDICOURT OLIVIER
Form 4 Vaxcyte, Inc. For: Dec 31 Filed by: Dhaliwal Harpreet S.
Form 144 Vaxcyte, Inc. Filed by: Dhaliwal Harpreet S.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.